CCG
ELV icon

Cypress Capital Group’s Elevance Health ELV Stock Holding History

Cypress Capital Group’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-501
Closed -$271K – 316
2024
Q2 		$271K Sell
501
-30
-6% -$15.9K 0.03% 260
2024
Q1 		$275K Sell
531
-1,565
-75% -$778K 0.03% 259
2023
Q4 		$988K Sell
2,096
-226
-10% -$105K 0.13% 143
2023
Q3 		$1.01M Buy
2,322
+1,619
+230% +$734K 0.15% 132
2023
Q2 		$312K Buy
703
+10
+1% +$4.61K 0.05% 256
2023
Q1 		$319K Hold
693
– – 0.05% 244
2022
Q4 		$355K Buy
+693
New +$352K 0.05% 237
2022
Q1 		– Sell
-772
Closed -$358K – 314
2021
Q4 		$358K Sell
772
-290
-27% -$122K 0.04% 241
2021
Q3 		$396K Sell
1,062
-71
-6% -$27K 0.05% 227
2021
Q2 		$433K Sell
1,133
-2
-0.2% -$764 0.06% 222
2021
Q1 		$407K Sell
1,135
-36
-3% -$11.6K 0.06% 224
2020
Q4 		$376K Buy
1,171
+21
+2% +$6.45K 0.06% 219
2020
Q3 		$309K Sell
1,150
-32
-3% -$8.61K 0.05% 217
2020
Q2 		$311K Buy
+1,182
New +$315K 0.06% 207
2018
Q2 		– Sell
-1,058
Closed -$232K – 228
2018
Q1 		$232K Buy
+1,058
New +$249K 0.05% 203

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Cypress Capital Group's ELV Position: Q3 2024 in Review

Cypress Capital Group sold out of Elevance Health (ELV) in Q3 2024, closing a stake of 501 shares — an estimated $271K sold.

Cypress Capital Group first reported a position in ELV in Q1 2018 and held it in 15 quarters. The position peaked at $1.01M in Q3 2023. 1,693 funds tracked by Wall St. Rank hold ELV as of Q3 2024.

  • Cypress Capital Group reported no remaining Elevance Health position as of Q3 2024 after selling out during the quarter.
  • Cypress Capital Group sold 501 Elevance Health shares in Q3 2024, an estimated $271K.
  • Cypress Capital Group first reported a position in Elevance Health in Q1 2018 and held it in 15 quarters.
  • Cypress Capital Group's Elevance Health position peaked at $1.01M in Q3 2023.
  • 1,693 funds tracked by Wall St. Rank held Elevance Health as of Q3 2024.

Based on Cypress Capital Group's 13F filing for Q3 2024, filed 8 Nov 2024.